Eslicarbazepine Acetate Tablet
Product Images NDC 60505-4658

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Eslicarbazepine Acetate (NDC 60505-4658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

This text appears to discuss fold change and 908 CT values in relation to medication dosage, specifically referring to medications like ADe (e.g., carbamazepine and primidone). The recommendation provided suggests a higher dose of oxcarbazepine may be needed.*

FDA Label Image

Figure3a.jpg (Figure3)

This document contains information related to changes in medication dosages for various drugs, including Azt, Gabapentin, Tanckritine, Levetiracetam, Phenobarbital, Phenytoin, Topiramate, and Valproate. It also discusses fold change and provides a recommendation for monitoring plasma phenytoin concentration in epilepsy patients for potential dose adjustment based on clinical response and serum levels of the drug.*

FDA Label Image

Figure3b.jpg (Figure3b)

This text discusses changes in fold change and 90% confidence intervals for various medications, including pigexta rolt, vettomin oH, simvastatin, rosuvastatin, oral contraceptives containing Sthinylestradiol, Levenorgestrel, and wartarn. It also mentions adjustments in doses for simvastatin and rosuvastatin based on clinically significant lipid changes. Additionally, it recommends the consideration of alternative non-hormonal birth control methods and emphasizes the need for patient monitoring to maintain IR.*

FDA Label Image

Figure4.jpg (Figure4)

This text provides information on the KM estimate of exit rate for a study involving ESLICARBAZEPINE ACETATE TABLETS. The results are presented in a tabular format with two study references mentioned - Study 1 and Study 2. Additionally, there are details about the dosage of ESLICARBAZEPINE ACETATE TABLETS used in the study.*

FDA Label Image

Figure5.jpg (Figure5)

FDA Label Image

Lbl200mg30.jpg (Lbl200mg30s)

This text provides information about a medication containing 200 mg of eslicarbazepine acetate in each tablet. The storage instructions recommend keeping the tablets at temperatures between 20-25°C (68-77°F) excursions allowed between 15-30°C (59-86°F). It advises keeping the container tightly closed, out of reach of children, and dispensing in a tight container as per USP guidelines. The usual dosage is specified as "Ses package insert." The packaging includes 30 tablets with an NDC code 60505-4658-3 for once daily use. The pharmacist is instructed to dispense a Medication Guide to each patient. The manufacturer is Apotex Corp.*

FDA Label Image

Lbl400mg30.jpg (Lbl400mg30s)

Each tablet contains 400 mg of eslicarbazepine acetate. This medication is stored between 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). The tablets are dispensed in a tight container and should be kept out of reach of children. The usual dosage information can be found in the package insert. This product is produced by Apotex Corp and manufactured in Toronto, Ontario, Canada. Pharmacists are instructed to dispense the enclosed Medication Guide to each patient.*

FDA Label Image

Lbl600mg60.jpg (Lbl600mg60s)

This text provides the essential information for a medication containing 600 mg of eslicarbazeping acetate in each tablet. The storage instructions indicate a temperature range of 20-25°C (68-77°F) with excursions allowed from 15-30°C (59-86°F). It also instructs to keep the tablets tightly closed and out of reach of children. The recommended dosage is not specified in this particular text, but it mentions the availability of a package insert. Additionally, it advises pharmacists to provide patients with a Medication Guide. The tablets are manufactured by Apotex Corp in Toronto, Canada.*

FDA Label Image

Lbl800mg30.jpg (Lbl800mg30s)

This is a description of a medication containing 800 mg of eslicarbazepine acetate in each tablet. The tablets should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted from 15°C to 30°C (59°F to 86°F). It is advised to keep the container tightly closed and out of reach of children. The recommended dosage information is found in the package insert. The medication is meant to be taken once daily, and it is important for pharmacists to dispense the enclosed Medication Guide to each patient. The manufacturer is Apotex Corp, with the tablets being manufactured in Toronto, Ontario, Canada.*

FDA Label Image

Structure.jpg (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.